Birmingham hospital merger to be first of many
December 15, 2006Debt-ridden Good Hope hospital trust is set to merge with one of the country's best hospitals, the neighbouring Heart of …
Government unveils plans for improved patient involvement
December 14, 2006The views of patients in local healthcare decision making is to be further enhanced by the creation of Local Involvement …
Chance missed to reform NHS finance controls, say managers
December 11, 2006A controversial NHS accounting system, in which in-debt trusts are penalised with budget cuts, will continue, despite protests from health …
National cancer network underpins prostate vaccine trial
December 11, 2006Research and Development
The UK's National Cancer Research Network has given its backing to a phase IIb trial of a promising vaccine for …
GSK buys antibody firm Domantis for
December 11, 2006Research and Development
GlaxoSmithKline has bought Cambridge-based antibody firm Domantis for £230 million.Domantis, a leader in developing the next generation of antibody therapies, …
Is optimisation the new sales mantra?
December 11, 2006Sales and Marketing NHS, sales, strategy
The pharmaceutical industry still refuses to fall out of love with large sales forces, but there are signs beginning to …
TroVax a step nearer to orphan status
December 8, 2006Research and Development
Oxford BioMedica's leading cancer immunotherapy vaccine has received a positive opinion as an orphan drug for renal cancer from the …
Closer scrutiny for high-risk clinical trials
December 8, 2006Research and Development
Wide-ranging changes will be made to the way clinical trials are conducted in the UK following the final report by …
New UK body to fast-track breakthrough research
December 8, 2006Research and Development
Faster approval of NHS clinical trials and NICE recommendations are almost certain following a fundamental shake-up in the way UK …
Novartis readies Prexige for European launch
December 8, 2006Research and Development, Sales and Marketing
Novartis will launch Prexige in its first European markets outside the UK next year following its EMEA approval for osteoarthritic …
UK uptake of new medicines ‘about right’ say doctors
December 7, 2006Sales and Marketing
Most UK doctors think the uptake of new medicines in the country is 'about right' according to a new survey …
Get the best from your R&D team
December 6, 2006Business Services, Research and Development R&D, recruitment
One of the key drivers of much of the recent merger and acquisition activity within the pharmaceutical industry is the …
New treatment for patients resistant to cancer drug Glivec
December 6, 2006Sales and Marketing
The first effective option for chronic myeloid leukaemia (CML) patients resistant or intolerant to prior treatment with Glivec has been …
Smoking cessation drug launched
December 5, 2006Sales and Marketing
Champix, Pfizer's potential blockbuster smoking cessation drug, has been launched in the UK.This first-in-class treatment is designed to activate the …
PAN Advertising sold to marketing services group Creston
December 5, 2006Medical Communications
One of the UK's last independent healthcare advertising agencies, PAN Advertising, has been sold to marketing services group Creston.Set up …
Cholesterol drug failure hits Pfizer
December 4, 2006Research and Development, Sales and Marketing
Pfizer has suffered a major blow with its decision to cancel late-stage pipeline torcetrapib following safety concerns.Torcetrapib, which raises 'good' …
Galen launches new COPD cough treatment
December 4, 2006Sales and Marketing
Erdotin, a new treatment that reduces the severity of 'productive' or phlegmy coughs in COPD patients, has been launched in …
England set for smoking ban from July
December 1, 2006Sales and Marketing
The United Kingdom will join the ranks of countries to ban smoking in public when, on 1 July 2007, England …
Work to begin on Cancer Reform Strategy for NHS
December 1, 2006Sales and Marketing
The government is to work with doctors, nurses, cancer charities and others to draw up a new Cancer Reform Strategy …
Kindler sets out new vision for Pfizer
December 1, 2006Sales and Marketing Pfizer, lipid
Pfizer's chief executive Jeffrey Kindler has set out plans for the company to renew itself as an R&D, in-licensing and …
Latest content
FibroFind appoints Lee Borthwick as CEO
